Carregant...
LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2
BACKGROUND: Mantle cell lymphoma (MCL) is considered an aggressive subtype of non-Hodgkin’s lymphoma with variable treatment responses. There is an urgent need to identify novel markers with prognostic and therapeutic value for MCL. Long non-coding RNAs (lncRNAs) have emerged as key regulators in ca...
Guardat en:
| Publicat a: | J Transl Med |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5175387/ https://ncbi.nlm.nih.gov/pubmed/27998273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-016-1100-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|